Rest In Power: Kevin B. Zeese, 1955-2020

We are sad to report that the co-founder and President of Common Sense for Drug Policy, Kevin B. Zeese, passed away on September Fifth, 2020. He is sorely missed.

Kevin was one of the nation's foremost authorities on drug policy issues. He worked on a wide array of drug related issues since he graduated from George Washington University Law School in 1980.

Rest In Power: Kevin B. Zeese, 1955-2020

We are sad to report that the co-founder and President of Common Sense for Drug Policy, Kevin B. Zeese, passed away on September Fifth, 2020. He is sorely missed.

Kevin was one of the nation's foremost authorities on drug policy issues. He worked on a wide array of drug related issues since he graduated from George Washington University Law School in 1980.

Kevin wrote for newspapers and journals on a range of drug issues, including an op-ed in the Wall Street Journal on the Colombian drug war. He also appeared on every major television network as a commentator. He served as a consultant to Walter Cronkite for the Discovery Channel special: The Drug Dilemma: War or Peace? He spoke at nationally recognized legal seminars and testified before Congress on drug related issues.

A Feb. 2005 interview with Kevin on the syndicated radio program Cultural Baggage is available. In April 2002, Kevin debated DEA Administrator Asa Hutchinson at a conference hosted by Rice University's James Baker Institute. Segments of the forum, "Moving Beyond the 'War on Drugs'," including the Zeese-Hutchinson debate, are available as streaming video. A listing of articles in which Kevin appears is available by clicking here.

He was the author of Drug Testing Legal Manual, Drug Testing Legal Manual and Practice Aids and co-author of Drug Law: Strategies and Tactics, all published by Clark Boardman Callaghan. Kevin served as editor of Drug Law Report for Clark Boardman Callaghan from 1983 to 1998. In addition, he was the author of Drug Prohibition and the Conscience of Nations. Mr. Zeese was the editor of Friedman and Szasz On Liberty and Drugs and edited numerous books on drug policy and manuals on criminal defense.

Kevin Zeese litigated a variety of drug policy-related issues. Among these are the medical use of marijuana, the use of the military and national guard in domestic drug enforcement, the spraying of herbicides in the United States and abroad on marijuana, drug testing of government workers and the right to privacy as it relates to marijuana in the home. He had been a legal advisor to needle exchange workers prosecuted for their anti-AIDS efforts, buyer's clubs who distribute marijuana to the seriously ill, and medical marijuana patients prosecuted for the medical use of marijuana.

Kevin facilitated the Alliance of Reform Organizations, a network of all the major reform organizations in the United States. He served on the Executive Committee of the Harm Reduction Coalition. He served on the Board of Directors of the Drug Policy Forum of Texas and was a Board member emeritus of the DrugSense.

He was a co-founder of the Drug Policy Foundation (now renamed the Drug Policy Alliance), where he served as Vice President and Counsel, and is a former Executive Director and Chief Counsel of the National Organization for the Reform of Marijuana Laws.

Zeese served on Baltimore Mayor Kurt L. Schmoke's Mayor's Working Group on Drug Policy Reform and served on San Francisco District Attorney Terence Hallinan's Harm Reduction Council. Both were efforts to implement a model urban drug policy. Zeese was also involved with advocacy related to the fatal shooting of Esequiel Hernandez, the legal rights of patients, doctors and their caregivers in California, and the UN General Assembly Special Session on drugs (the UNGASS).

In 2000, Kevin Zeese was the recipient of the Richard J. Dennis DrugPeace Award for Lifetime Achievement in the Field of Drug Policy Reform from the Drug Policy Foundation at its 13th Annual International Conference on Drug Policy Reform.

People Incarcerated in the US

"ƒ The U.S. prison population was 1,230,100 at yearend 2022, a 2% increase from yearend 2021 (1,205,100).

"ƒ The number of females in state or federal prison increased almost 5% from yearend 2021 (83,700) to yearend 2022 (87,800).

"ƒ Nine states and the BOP increased their total prison populations by over 1,000 persons from yearend 2021 to yearend 2022.

"ƒ State correctional authorities had jurisdiction over 1,039,500 persons sentenced to at least 1 year in prison in 2022, while the BOP had legal authority over 146,100 persons with similar sentences.

Receipt of Opioid Use Disorder Treatments Prior to Fatal Overdoses and Comparison to No Treatment

"The findings revealed that exposures to MOUD, even if not continued throughout the six-month exposure period was associated with reduced risk of a fatal poisoning compared to non-MOUD forms of treatment and no treatment exposure. It is also clear that risk of death associated with exposure to non-MOUD forms of treatment was no less than that for no treatment; indeed, non-MOUD treatment might have produced worse outcomes than no treatment.

Use of Prescription Fentanyl and Illegally Made Fentanyl in the US According to the National Survey on Drug Use and Health

"Among people aged 12 or older in 2022, 0.4 percent (or 991,000 people) misused fentanyl in the past year, including 0.1 percent of adolescents aged 12 to 17, 0.2 percent of young adults aged 18 to 25, and 0.4 percent of adults aged 26 or older (Table A.12B). Corresponding estimated numbers of people who misused fentanyl in the past year were 34,000 adolescents aged 12 to 17, 75,000 young adults aged 18 to 25, and 882,000 adults aged 26 or older.

"IMF [Illegally Made Fentanyl] Use

Development of Prescribed Safer Supply in Canada

"The extremely potent and toxic nature of ISOs [Illicit/Synthetic Opioids] has rendered them the primary cause of overdose fatalities while consequently presenting major challenges for the menu of available interventions. Many existing interventions have mostly aimed at either manipulating the drug use environment to be safer (e.g., supervised consumption) or reactively treating underlying drug use disorders (OAT) or overdoses (naloxone).

Overdose Prevention Centers, Crime, and Public Order

"Results  No significant changes were detected in violent crimes or property crimes recorded by police, 911 calls for crime or medical incidents, or 311 calls regarding drug use or unsanitary conditions observed in the vicinity of the OPCs. There was a significant decline in low-level drug enforcement, as reflected by a reduction in arrests for drug possession near the OPCs of 82.7% (95% CI, −89.9% to −70.4%) and a reduction in their broader neighborhoods of 74.5% (95% CI, −87.0% to −50.0%).

Subscribe to